GT Biopharma (GTBP) had the highest return between 2012 and 2013 by a US stock, returning 474,300,206%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2012-2013 | 474,300,206% |
Cenntro Electric (CENN) | 2012-2013 | 114,285,614.27% |
QXO (QXO) | 2012-2013 | 4,704,100% |
Avita Medical (RCEL) | 2012-2013 | 3,199,900% |
Xcel Brands (XELB) | 2012-2013 | 2,333,233.33% |
Anfield Energy (AEC) | 2012-2013 | 99,583.54% |
Versus Systems Inc. (VS) | 2012-2013 | 61,302.21% |
Prairie Operating Co Common Stock (PROP) | 2012-2013 | 48,028.35% |
Rezolute (RZLT) | 2012-2013 | 31,076.47% |
Lipocine (LPCN) | 2012-2013 | 27,950% |
Cementos Pacasmayo SAA ADR (CPAC) | 2012-2013 | 15,519.46% |
Cocrystal Pharma (COCP) | 2012-2013 | 15,260% |
Nixxy (NIXX) | 2012-2013 | 14,300% |
Clearpoint Neuro (CLPT) | 2012-2013 | 7,633.33% |
Actinium Pharmaceuticals (ATNM) | 2012-2013 | 5,789.99% |
Akari Therapeutics (AKTX) | 2012-2013 | 5,580% |
Nutex Health (NUTX) | 2012-2013 | 5,394.51% |
Par Pacific (PARR) | 2012-2013 | 3,616.67% |
NextTrip (NTRP) | 2012-2013 | 2,620.59% |
ACADIA Pharmaceuticals (ACAD) | 2012-2013 | 2,171.82% |
Aurinia Pharmaceuticals (AUPH) | 2012-2013 | 2,113.93% |
Supercom (SPCB) | 2012-2013 | 2,074.15% |
Coda Octopus (CODA) | 2012-2013 | 1,578.57% |
Himax Technologies (HIMX) | 2012-2013 | 1,480.9% |
Xpel (XPEL) | 2012-2013 | 1,324.44% |